251 related articles for article (PubMed ID: 31706013)
1. MiRNA-483-5p is involved in the pathogenesis of osteoporosis by promoting osteoclast differentiation.
Li K; Chen S; Cai P; Chen K; Li L; Yang X; Yi J; Luo X; Du Y; Zheng H
Mol Cell Probes; 2020 Feb; 49():101479. PubMed ID: 31706013
[TBL] [Abstract][Full Text] [Related]
2. MiR-125a-5p promotes osteoclastogenesis by targeting TNFRSF1B.
Sun L; Lian JX; Meng S
Cell Mol Biol Lett; 2019; 24():23. PubMed ID: 30976285
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-539 promotes osteoblast proliferation and differentiation and osteoclast apoptosis through the AXNA-dependent Wnt signaling pathway in osteoporotic rats.
Zhu XB; Lin WJ; Lv C; Wang L; Huang ZX; Yang SW; Chen X
J Cell Biochem; 2018 Nov; 119(10):8346-8358. PubMed ID: 29893431
[TBL] [Abstract][Full Text] [Related]
4. Pseudogene PTENP1 sponges miR-214 to regulate the expression of PTEN to modulate osteoclast differentiation and attenuate osteoporosis.
Wang CG; Wang L; Yang T; Su SL; Hu YH; Zhong D
Cytotherapy; 2020 Aug; 22(8):412-423. PubMed ID: 32561161
[TBL] [Abstract][Full Text] [Related]
5. Reduced miR-144-3p expression in serum and bone mediates osteoporosis pathogenesis by targeting RANK.
Wang C; He H; Wang L; Jiang Y; Xu Y
Biochem Cell Biol; 2018 Oct; 96(5):627-635. PubMed ID: 29334613
[TBL] [Abstract][Full Text] [Related]
6. MiR-503 regulates osteoclastogenesis via targeting RANK.
Chen C; Cheng P; Xie H; Zhou HD; Wu XP; Liao EY; Luo XH
J Bone Miner Res; 2014 Feb; 29(2):338-47. PubMed ID: 23821519
[TBL] [Abstract][Full Text] [Related]
7. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
[TBL] [Abstract][Full Text] [Related]
8. circ_0029463 promotes osteoclast differentiation by mediating miR-134-5p/Rab27a axis.
Tang L; Yuan L; Yan J; Ge J; Lian Z; Li Z
J Orthop Surg Res; 2024 Feb; 19(1):128. PubMed ID: 38326867
[TBL] [Abstract][Full Text] [Related]
9. mmu-miR-185 regulates osteoclasts differentiation and migration by targeting Btk.
He D; Jiao Y; Xu J; Luo J; Cui Y; Han X; Zhao H
J Gene Med; 2024 May; 26(5):e3687. PubMed ID: 38690623
[TBL] [Abstract][Full Text] [Related]
10. A potential therapeutic target for regulating osteoporosis via suppression of osteoclast differentiation.
Sun Q; Zhang B; Zhu W; Wei W; Ma J; Tay FR
J Dent; 2019 Mar; 82():91-97. PubMed ID: 30716449
[TBL] [Abstract][Full Text] [Related]
11. MiR-1224-5p modulates osteogenesis by coordinating osteoblast/osteoclast differentiation via the Rap1 signaling target ADCY2.
Hu L; Xie X; Xue H; Wang T; Panayi AC; Lin Z; Xiong Y; Cao F; Yan C; Chen L; Cheng P; Zha K; Sun Y; Liu G; Yu C; Hu Y; Tao R; Zhou W; Mi B; Liu G
Exp Mol Med; 2022 Jul; 54(7):961-972. PubMed ID: 35831436
[TBL] [Abstract][Full Text] [Related]
12. ATF1/miR-214-5p/ITGA7 axis promotes osteoclastogenesis to alter OVX-induced bone absorption.
Liu LL; Xiao YS; Huang WM; Liu S; Huang LX; Zhong JH; Jia P; Liu WY
Mol Med; 2022 May; 28(1):56. PubMed ID: 35568813
[TBL] [Abstract][Full Text] [Related]
13. miR-21-5p targets SKP2 to reduce osteoclastogenesis in a mouse model of osteoporosis.
Huang Y; Yang Y; Wang J; Yao S; Yao T; Xu Y; Chen Z; Yuan P; Gao J; Shen S; Ma J
J Biol Chem; 2021; 296():100617. PubMed ID: 33811860
[TBL] [Abstract][Full Text] [Related]
14. MiR-221-5p/Smad3 axis in osteoclastogenesis and its function: Potential therapeutic target for osteoporosis.
Guo M; Liu N; Guo Z
Steroids; 2022 Sep; 185():109063. PubMed ID: 35700796
[TBL] [Abstract][Full Text] [Related]
15. Osteoclastogenic capacity of peripheral blood mononuclear cells is not different between women with and without osteoporosis.
Koek WNH; van der Eerden BCJ; Alves RDAM; van Driel M; Schreuders-Koedam M; Zillikens MC; van Leeuwen JPTM
Bone; 2017 Feb; 95():108-114. PubMed ID: 27845263
[TBL] [Abstract][Full Text] [Related]
16. Osteoclast-derived miR-23a-5p-containing exosomes inhibit osteogenic differentiation by regulating Runx2.
Yang JX; Xie P; Li YS; Wen T; Yang XC
Cell Signal; 2020 Jun; 70():109504. PubMed ID: 31857240
[TBL] [Abstract][Full Text] [Related]
17. Osteoclast signaling-targeting miR-146a-3p and miR-155-5p are downregulated in Paget's disease of bone.
Stephens E; Roy M; Bisson M; Nguyen HD; Scott MS; Boire G; Bouchard L; Roux S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165852. PubMed ID: 32485219
[TBL] [Abstract][Full Text] [Related]
18. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
19. MiR-124 Attenuates Osteoclastogenic Differentiation of Bone Marrow Monocytes Via Targeting Rab27a.
Tang L; Yin Y; Liu J; Li Z; Lu X
Cell Physiol Biochem; 2017; 43(4):1663-1672. PubMed ID: 29045940
[TBL] [Abstract][Full Text] [Related]
20. Validation of downregulated microRNAs during osteoclast formation and osteoporosis progression.
Ma Y; Shan Z; Ma J; Wang Q; Chu J; Xu P; Qin A; Fan S
Mol Med Rep; 2016 Mar; 13(3):2273-80. PubMed ID: 26783047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
